|
GB1047518A
(en)
*
|
1963-06-11 |
1966-11-02 |
Glaxo Lab Ltd |
17ª-monoesters of 11,17,21-trihydroxy steroid compounds
|
|
NL128816C
(https=)
*
|
1965-04-22 |
|
|
|
|
GB1159490A
(en)
*
|
1966-02-09 |
1969-07-23 |
Boots Pure Drug Co Ltd |
Improvements in Acylated Steroids
|
|
GB1200886A
(en)
*
|
1966-09-23 |
1970-08-05 |
Allen & Hanburys Ltd |
Phenylaminoethanol derivatives
|
|
US3937838A
(en)
*
|
1966-10-19 |
1976-02-10 |
Aktiebolaget Draco |
Orally active bronchospasmolytic compounds and their preparation
|
|
US3639434A
(en)
*
|
1967-02-02 |
1972-02-01 |
Boots Pure Drug Co Ltd |
17-acyloxysteroids and their manufacture
|
|
US3780177A
(en)
*
|
1967-06-16 |
1973-12-18 |
Warner Lambert Co |
17-butyrate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use
|
|
CH510655A
(de)
*
|
1967-11-17 |
1971-07-31 |
Ciba Geigy Ag |
Verfahren zur Herstellung neuer Halogenpregnadiene
|
|
GB1253831A
(en)
*
|
1968-01-19 |
1971-11-17 |
Glaxo Lab Ltd |
9alpha,21-DIHALOPREGNANE COMPOUNDS
|
|
US3700681A
(en)
*
|
1971-02-16 |
1972-10-24 |
Pfizer |
2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines
|
|
US3947478A
(en)
*
|
1972-01-12 |
1976-03-30 |
Akzona Incorporated |
Alkylated 3,20-diketo-Δ4 -steroids of the pregnane series
|
|
US3994974A
(en)
*
|
1972-02-05 |
1976-11-30 |
Yamanouchi Pharmaceutical Co., Ltd. |
α-Aminomethylbenzyl alcohol derivatives
|
|
SE378109B
(https=)
*
|
1972-05-19 |
1975-08-18 |
Bofors Ab |
|
|
SE378110B
(https=)
*
|
1972-05-19 |
1975-08-18 |
Bofors Ab |
|
|
US3992534A
(en)
*
|
1972-05-19 |
1976-11-16 |
Ab Bofors |
Compositions and method of treating with component B of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steriods
|
|
FR2231374B1
(https=)
*
|
1973-05-30 |
1976-10-22 |
Jouveinal Sa |
|
|
US4098804A
(en)
*
|
1973-05-30 |
1978-07-04 |
Jouveinal S.A. |
Esters of 21-thiol prednisone and prednisolone
|
|
US4011258A
(en)
*
|
1973-06-21 |
1977-03-08 |
Aktiebolaget Draco |
Orally active bronchospasmolytic compounds
|
|
ZA744259B
(en)
*
|
1973-08-17 |
1975-06-25 |
American Cyanamid Co |
Topical steroid
|
|
US3980778A
(en)
*
|
1973-10-25 |
1976-09-14 |
The Upjohn Company |
Anti-inflammatory steroid
|
|
NL7502252A
(nl)
*
|
1974-02-27 |
1975-08-29 |
Pierrel Spa |
Werkwijze voor het bereiden van een geneesmid- del met anti-inflammatoire werking, gevormd ge- neesmiddel verkregen volgens deze werkwijze alsmede werkwijze voor het bereiden van in het geneesmiddel gebruikte nieuwe steroiden.
|
|
DE2655570A1
(de)
*
|
1975-12-12 |
1977-06-16 |
Ciba Geigy Ag |
Neue polyhalogensteroide und verfahren zu ihrer herstellung
|
|
US4124707A
(en)
*
|
1976-12-22 |
1978-11-07 |
Schering Corporation |
7α-Halogeno-3,20-dioxo-1,4-pregnadienes, methods for their manufacture, their use as anti-inflammatory agents, and pharmaceutical formulations useful therefor
|
|
US4081541A
(en)
*
|
1976-12-28 |
1978-03-28 |
Rorer Italiana S.P.A. |
Steroid derivatives
|
|
DE2735110A1
(de)
*
|
1977-08-04 |
1979-02-15 |
Hoechst Ag |
Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung
|
|
JPS6040439B2
(ja)
*
|
1978-03-29 |
1985-09-11 |
大正製薬株式会社 |
ヒドロコルチゾン誘導体
|
|
JPS56138200A
(en)
*
|
1980-02-15 |
1981-10-28 |
Glaxo Group Ltd |
Androstane carbothioate compound
|
|
DE3163871D1
(en)
*
|
1980-07-09 |
1984-07-05 |
Draco Ab |
1-(dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates
|
|
US4298604B1
(en)
*
|
1980-10-06 |
1998-12-22 |
Schering Corp |
Clotrimazole-betamethasone dipropionate combination
|
|
ATE8790T1
(de)
*
|
1981-02-02 |
1984-08-15 |
Schering Corporation |
Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
|
|
DE3133081A1
(de)
*
|
1981-08-18 |
1983-03-10 |
Schering Ag, 1000 Berlin Und 4619 Bergkamen |
Neue 6(alpha)-methylprednisolon-derivate, ihre herstellung und verwendung
|
|
US4472392A
(en)
*
|
1983-01-21 |
1984-09-18 |
The Upjohn Company |
Sulfonate containing ester prodrugs of corticosteroids
|
|
ZW6584A1
(en)
*
|
1983-04-18 |
1985-04-17 |
Glaxo Group Ltd |
Phenethanolamine derivatives
|
|
CA1240708A
(en)
*
|
1983-11-15 |
1988-08-16 |
Johannes K. Minderhoud |
Process for the preparation of hydrocarbons
|
|
CA1261835A
(en)
*
|
1984-08-20 |
1989-09-26 |
Masaaki Toda |
(fused) benz(thio)amides
|
|
GB8607294D0
(en)
*
|
1985-04-17 |
1986-04-30 |
Ici America Inc |
Heterocyclic amide derivatives
|
|
US4826868A
(en)
*
|
1986-05-29 |
1989-05-02 |
Ortho Pharmaceutical Corporation |
1,5-Diaryl-3-substituted pyrazoles pharmaceutical compositions and use
|
|
US4783259A
(en)
*
|
1986-07-07 |
1988-11-08 |
Wade Charles E |
Helical coil filter element
|
|
CA1326662C
(en)
*
|
1988-03-09 |
1994-02-01 |
Yutaka Mizushima |
11.beta.,17.,21-trihydroxy-1,4-pregnadiene-3,20-dione 21-[(e,e)-3,7,11-trimethyl-2,6,10-dodecatrienoate]
|
|
US5278156A
(en)
*
|
1988-03-09 |
1994-01-11 |
Kuraray Co., Ltd. |
11-beta, 17-alpha, 21-trihydroxy-1, 4-pregnadiene-3, 20 21-[(E-E)-3,7, 11-trimethyl-2,6,10-dodecatrienoate]
|
|
GR1001529B
(el)
*
|
1990-09-07 |
1994-03-31 |
Elmuquimica Farm Sl |
Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
|
|
AU663471B2
(en)
*
|
1990-09-10 |
1995-10-12 |
Merck Sharp & Dohme Corp. |
Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
|
|
US5565473A
(en)
*
|
1990-10-12 |
1996-10-15 |
Merck Frosst Canada, Inc. |
Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
|
|
US6127353A
(en)
*
|
1991-09-06 |
2000-10-03 |
Schering Corporation |
Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
|
|
US5225202A
(en)
*
|
1991-09-30 |
1993-07-06 |
E. R. Squibb & Sons, Inc. |
Enteric coated pharmaceutical compositions
|
|
WO1995014680A1
(en)
*
|
1993-11-26 |
1995-06-01 |
Pfizer Inc. |
3-aryl-2-isoxazolines as antiinflammatory agents
|
|
US5837699A
(en)
*
|
1994-01-27 |
1998-11-17 |
Schering Corporation |
Use of mometasone furoate for treating upper airway passage diseases
|
|
TW438585B
(en)
*
|
1995-02-06 |
2001-06-07 |
Astra Ab |
Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections
|
|
US5976573A
(en)
*
|
1996-07-03 |
1999-11-02 |
Rorer Pharmaceutical Products Inc. |
Aqueous-based pharmaceutical composition
|
|
US7122207B2
(en)
*
|
1998-05-22 |
2006-10-17 |
Bristol-Myers Squibb Company |
High drug load acid labile pharmaceutical composition
|
|
US6727272B1
(en)
*
|
2002-07-15 |
2004-04-27 |
Unitech Pharmaceuticals, Inc. |
Leflunomide analogs for treating rheumatoid arthritis
|
|
JP2007504123A
(ja)
*
|
2003-08-29 |
2007-03-01 |
ランバクシー ラボラトリーズ リミテッド |
Ｉｖ型ホスホジエステラーゼの阻害剤
|
|
US20080009535A1
(en)
*
|
2004-08-30 |
2008-01-10 |
Sarala Balachandran |
Inhibitors of phosphodiesterase type-IV
|
|
ES2370788T3
(es)
*
|
2005-02-07 |
2011-12-22 |
Aerocrine Ab |
Controlar flujo de aliento exhalado durante análisis.
|
|
DE102005044813A1
(de)
*
|
2005-05-19 |
2007-10-04 |
Grünenthal GmbH |
Substituierte Spiro-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
|
|
AR055395A1
(es)
*
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
|
|
RU2008119323A
(ru)
*
|
2005-10-19 |
2009-11-27 |
Рэнбакси Лабораториз Лимитед (In) |
Фармацевтические композиции мускаринового рецептора
|
|
WO2007045980A1
(en)
*
|
2005-10-19 |
2007-04-26 |
Ranbaxy Laboratories Limited |
Compositions of phosphodiesterase type iv inhibitors
|